- CEO
- Mohammad Baig
- Full Time Employees
- 9
- Sector
- Process industries
- Industry
- Containers/Packaging
- Address
- Lahore Pakistan
- IPO Date
- May 30, 1994
- Business
- Balochistan Glass Limited is a Pakistan-based manufacturing company engaged in the production, marketing, and distribution of glass containers, tableware, and specialty packaging solutions. Founded in 1980 and headquartered in Lahore, Pakistan, the company operates within the industrial packaging and consumer goods sectors, catering to pharmaceutical enterprises, food and beverage processors, hospitality providers, and retail household consumers. The company's core product portfolio encompasses tableware glassware, including pressed and blown glass tumblers, stemware, mugs, tea sets, water sets, bowls, plates, and decorative serving ware marketed under brand lines such as Marimax; pharmaceutical glass packaging, including USP Type I, Type II, and Type III flint and amber glass bottles, vials, dropper containers, syrup bottles, and medical infusion jars designed for chemical resistance and liquid preservation; food and beverage containers, including narrow-neck beverage bottles, wide-mouth food jars, condiment bottles, juice containers, and carbonated soft drink bottles; and specialized industrial glass services, including custom mold fabrication, surface decoration, automated labeling, printing, and tailored packaging design. Balochistan Glass Limited maintains manufacturing facilities located in Hub, Lasbela District in Balochistan, as well as production units in Sheikhupura and Lahore in Punjab, serving clients across Pakistan and regional export markets. In recent developments, Balochistan Glass Limited has pursued operational revamping and financial reorganization to strengthen its competitive position and restore sustained manufacturing efficiency. These operational changes include technological upgrades to glass melting furnaces and forming machinery, the adoption of energy-efficient fuel management systems to curb production costs, the enhancement of automated defect-detection and quality assurance inspection lines, and the reprofiling of debt obligations with financial institutions to stabilize liquidity and working capital. Additionally, the company has broadened its commercial alliances with domestic pharmaceutical manufacturers and expanded its distribution footprint to capture export opportunities for specialty glass packaging across Central Asia and the Middle East.